VCYT Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Veracyte, Inc.
News originally published by
GlobeNewswireVCYT’s stock is down more than 50%; Ademi LLP is investigating Veracyte for potential securities fraud.
CLICK HERE TO JOIN
MILWAUKEE, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against Veracyte (Nasdaq: VCYT). The investigation results from inaccurate statements Veracyte may have made regarding its financial statements, business operations and prospects.
Are You a VCYT Shareholder?
If you’re losing money on your Veracyte investment, Ademi LLP would like to hear from you to discuss your rights.
You may also contact Guri Ademi at gademi@ademilaw.com or toll-free at 866-264-3995.
There is no cost or obligation to you.
What Is Ademi LLP Investigating?
The Company’s previous claims about expectations for its Decipher Prostate testing.
What Should VCYT Shareholders Do?
Contact Ademi LLP to discuss your rights and our investigation. There is no cost or obligation to you.
Guri Ademi
Ademi LLP
Toll Free: (866) 264-3995
Email: gademi@ademilaw.com
About Ademi LLP
Ademi LLP represents investors in shareholder litigation involving mergers, acquisitions, buyouts, and individual shareholder rights.
Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Ademi LLP
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
